Metoprolol Succinate Extended-Release Tablets recall: CGMP Deviations
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC…
Why was Metoprolol Succinate Extended-Release Tablets recalled?
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Batch 2447J211
- Product
- Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC…
- Recalling firm
- CARDINAL HEALTHCARE
- Quantity
- 1 unit
- Distribution
- Nationwide USA
- Recall date
- January 3, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)